Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLCO3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHE41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DBI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTRHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCGF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERP29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COMTD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on